Quest AD-Detect® Phosphorylated tau181(p-tau181), Plasma
Test Code
13690
84393
Clinical Significance
Quest AD-Detect® Phosphorylated tau181(p-tau181), Plasma - p-tau181 is a diagnostic biomarker for Alzheimer's Disease (AD) that is useful in identifying patients with underlying AD tau pathology. It can predict the cognitive decline in AD/MCI patients and correlates with amyloid and tau PET results.
Test Resources
Test Details
Dietary supplements containing biotin may interfere in assays and may skew results to be either falsely high or falsely low. For patients receiving the recommended daily doses of biotin, draw samples at least 8 hours following the last biotin supplementation. For patients on mega-doses of biotin supplements, draw samples at least 72 hours following the last biotin supplementation.
Methodology
Electrochemiluminescence (ECLIA)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
| <55 years | ≤0.86 pg/mL |
| ≥55 years | ≤1.07 pg/mL |
Alternative Name(s)
PhosphoTau-181P
Preferred Specimen(s)
1 mL plasma collected in EDTA (lavender-top) tube
Minimum Volume
0.5 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 14 days
Refrigerated: 22 days
Frozen: 22 days
Reject Criteria
Hemolysis
Setup Schedule
1 mL plasma collected in EDTA (lavender-top) tube
0.5 mL
Transport tube
Room temperature
Room temperature: 14 days
Refrigerated: 22 days
Frozen: 22 days
Refrigerated: 22 days
Frozen: 22 days
Hemolysis